treatments geared toward specific symptoms, such as the recently approved brexipiprazole for agitation, may also be used to tackle various symptoms that arise due to alzheimer’s disease.
other non-medicinal therapies, including music, animal, and cognitive stimulation therapy, are also approved in canada as complementary approaches to treating alzheimer’s that can help reduce symptoms and improve quality of life.
additionally, there is a heightened understanding of the vital role in supporting both patients and caregivers, recognizing care partners as the “unsung heroes in the field of dementia care,” wong said.
natasha jacobs, advisory group and referral service manager at the alzheimer society of canada, explains that as the disease progresses gradually, symptoms may intertwine, making it more challenging to pinpoint transitions. in navigating this evolution, jacobs advocates for a person-centred approach, championing the belief that individuals affected by the disease deserve to be treated with dignity and respect.
“a key point to remember is although a person loses many abilities as dementia progresses, it is important to focus on the abilities that remain,” jacobs said.
in the early stage of the disease, jacobs underscores the importance of preserving independence, as individuals can still actively contribute to their own care plans. as the middle stage ushers in a more noticeable decline, support with daily tasks becomes crucial.
strategies to minimize risks, such as wandering, become pivotal and may help sustain a meaningful quality of life. in the late stage of the disease, where verbal communication and self-care abilities significantly diminish, jacobs says that individuals require around-the-clock care. the end-of-life phase, on the other hand, prioritizes comfort, addressing both physical and emotional needs to improve the overall quality of life.